Eckert P, Barbey-Schneider M, Schneider R, Sauerwein W
Anaesthesist. 1982 Feb;31(2):90-4.
In a first period of two years the total number of patients with re-laparotomy was 1.7 per cent (41/2412). The death rate in these cases was 48.8 per cent. In a second period of nine months we found a re-laparotomy rate of 0.69 per cent (7/1022). The death rate of these seven cases with re-laparotomy amounted to 14.3 per cent. All together in the second period the number of re-laparotomies decreased evidently and the postoperative course was less complicated. The experience with the patients who died in the first period was a reason to classify the cases in a group with particular risk. For this reason the endangered patients were operated in the second period by the same surgeon. The medication and intensive care were the same, but we instilled ten g of a immune globulin into the abdominal cavity of these endangered patients. The reasons and the indication of this therapy will be discussed.
在为期两年的第一阶段,再次剖腹手术患者的总数为1.7%(41/2412)。这些病例的死亡率为48.8%。在为期九个月的第二阶段,我们发现再次剖腹手术率为0.69%(7/1022)。这7例再次剖腹手术病例的死亡率为14.3%。在第二阶段,再次剖腹手术的数量总体上明显减少,术后病程的复杂性也降低了。第一阶段死亡患者的情况促使我们将这些病例归类为具有特殊风险的一组。因此,在第二阶段,由同一位外科医生为濒危患者进行手术。用药和重症监护相同,但我们向这些濒危患者的腹腔内注入了10克免疫球蛋白。将讨论这种治疗方法的原因和适应证。